Trade

with

Abiomed Inc
(NASDAQ: ABMD)
AdChoices
24.18
+0.08
+0.33%
After Hours :
24.18
0.00
0.00%

Open

24.17

Previous Close

24.10

Volume (Avg)

145.42k (223.48k)

Day's Range

24.07-24.61

52Wk Range

20.29-30.77

Market Cap.

975.17M

Dividend Rate ( Yield )

-

Beta

1.67

Shares Outstanding

40.46M

P/E Ratio (EPS)

136.99 (0.18)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 183.64M

    • Net Income

    • 7.35M

    • Market Cap.

    • 975.17M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 3.88

    • PEG (Price/Earnings Growth) Ratio

    • 1.46

    • Beta

    • 1.67

    • Forward P/E

    • 153.85

    • Price/Sales

    • 5.34

    • Price/Book Value

    • 5.74

    • Price/Cash flow

    • 37.17

      • EBITDA

      • 10.87M

      • Return on Capital %

      • 3.91

      • Return on Equity %

      • 4.73

      • Return on Assets %

      • 3.91

      • Book Value/Share

      • 4.21

      • Shares Outstanding

      • 40.46M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 35.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • 0.29

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 14.40

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -51.00

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 20.19

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 79.83

            • 64.08

            • Pre-Tax Margin

            • 4.40

            • 15.19

            • Net Profit Margin

            • 3.88

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 78.50

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -3.00

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -3.80

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.34

              • Current Ratio

              • 4.39

              • 2.55

              • Quick Ratio

              • 3.80

              • 1.83

              • Interest Coverage

              • -

              • 11.70

              • Leverage Ratio

              • 1.21

              • 1.86

              • Book Value/Share

              • 4.21

              • 11.67

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 135.14

                • 35.09

                • P/E Ratio 5-Year High

                • 175.27

                • 224.03

                • P/E Ratio 5-Year Low

                • 44.43

                • 60.23

                • Price/Sales Ratio

                • 5.22

                • 3.24

                • Price/Book Value

                • 5.61

                • 3.29

                • Price/Cash Flow Ratio

                • 37.17

                • 19.05

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 4.73

                    (-2.10)

                  • 12.33

                    (18.16)

                  • Return on Assets %

                    (5-Year Average)

                  • 3.91

                    (-1.80)

                  • 6.62

                    (8.69)

                  • Return on Capital %

                    (5-Year Average)

                  • 4.73

                    (-2.10)

                  • 8.49

                    (11.48)

                  • Income/Employee

                  • 14.41k

                  • 34.11k

                  • Inventory Turnover

                  • 2.52

                  • 2.77

                  • Asset Turnover

                  • 1.01

                  • 0.51

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  8.36M
                  Operating Margin
                  4.55
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  37.17
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  75.92%

                  Mutual Fund Ownership

                  52.98%

                  Float

                  63.19%

                  5% / Insider Ownership

                  6.81%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • PrimeCap Odyssey Aggressive Growth Fund

                  •  

                    2,668,073

                  • -0.11

                  • 6.61

                  • PrimeCap Odyssey Growth Fund

                  •  

                    1,914,800

                  • 0.00

                  • 4.74

                  • Delaware Smid Cap Growth Fund

                  •  

                    1,622,796

                  • -1.18

                  • 4.02

                  • Delaware SMID Cap Growth Collective Investment Trust

                  •  

                    1,622,796

                  • -1.18

                  • 4.02

                  • Vanguard Explorer Fund

                  •  

                    1,299,300

                  • 52.61

                  • 3.22

                  • Vanguard US Opportunities

                  •  

                    1,143,617

                  • -1.63

                  • 2.83

                  • Delaware VIP Smid Cap Growth Series

                  •  

                    739,925

                  • -1.72

                  • 1.83

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    738,706

                  • 0.20

                  • 1.77

                  • Delaware Select Growth Fund

                  •  

                    638,000

                  • -7.89

                  • 1.58

                  • Vanguard Small Cap Index

                  •  

                    633,065

                  • 1.08

                  • 1.56

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • PRIMECAP Management Company

                  •  

                    5,726,490

                  • -0.44%

                  • 14.19

                  • Delaware Management Business Trust

                  •  

                    3,496,853

                  • -34.94%

                  • 8.66

                  • Essex Woodlands Health Ventures

                  •  

                    3,150,000

                  • 0.00%

                  • 7.80

                  • Blair William & Co

                  •  

                    2,651,412

                  • -0.30%

                  • 6.57

                  • Wellington Management Company, LLP

                  •  

                    2,565,474

                  • +60.65%

                  • 6.36

                  • Vanguard Group, Inc.

                  •  

                    2,420,747

                  • +0.26%

                  • 6.00

                  • Palo Alto Investors, LLC

                  •  

                    2,207,489

                  • -49.88%

                  • 5.47

                  • BlackRock Fund Advisors

                  •  

                    2,008,834

                  • -3.81%

                  • 4.98

                  • Next Century Growth Investors LLC

                  •  

                    1,695,337

                  • -3.76%

                  • 4.20

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Devices

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  Abiomed Inc is a Delaware corporation incorporated on June 4, 1987. The Company is engaged in providing mechanical circulatory support devices and it offers a continuum of care in heart recovery to heart failure patients. The Company...more develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. Its products are used in the cardiac catheterization lab, or cath lab, by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. The Companys product portfolio includes; Impella 2.5, Impella CP, Impella RP, A...moreB5000, Symphony, and Impella 5.0 & Impella LD. The Companys Impella 2.5 catheter is a percutaneous micro heart pump with an integrated motor and sensors for use mainly in interventional cardiology. The device is designed mainly for use by interventional cardiologists to support patients in the cath lab who may require assistance to maintain their circulation. The Impella 5.0 catheter and Impella LD are percutaneous micro heart pumps with integrated motors and sensors for use mainly in the heart surgery suite. These devices are designed to support patients who require higher levels of circulatory support as compared to the Impella 2.5. The Impella RP is a percutaneous catheter-based axial flow pump that is designed to allow greater than four liters of flow per minute and to provide the flow and pressure needed to compensate for right heart failure. The Company manufactures & sells the AB5000 Circulatory Support System for the temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. The Company faces competition from Getinge (Maquet Cardiovascular), Teleflex Inc., Thoratec Corporation, HeartWare International Inc., Jarvik Heart, Terumo Heart, Inc. and CardiacAssist Inc. The Companys business is subject to extensive federal, state, local and foreign regulation.lessless

                  Key People

                  Mr. Michael R. Minogue

                  CEO/Chairman of the Board/Director/President

                  Mr. Robert L. Bowen

                  CFO/Chief Accounting Officer/Treasurer/Vice President

                  Mr. Andrew J. Greenfield

                  General Manager, Divisional/Vice President

                  Mr. Michael G. Howley

                  General Manager, Divisional/Vice President

                  Ms. Dorothy E. Puhy

                  Director

                  • Abiomed Inc

                  • 22 Cherry Hill Drive

                  • Danvers, MA 01923

                  • USA.Map

                  • Phone: +1 978 646-1400

                  • Fax: +1 978 777-8411

                  • abiomed.com

                  Incorporated

                  1987

                  Employees

                  511

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: